Research Objectivity amidst Investment Banking Relationships

James is an equity research analyst at a reputable investment firm. Recently, his firm was involved in an underwriting deal for a biotechnology company, which has been one of his coverage stocks. During the due diligence process for the offering, James discovered information that he believes would greatly affect the company’s stock price. He is under pressure to issue a positive research report to support the underwriting process. As per the CFA Institute's Research Objectivity Standards, how should James proceed?